Appendix 1. | Survey |
| What year of LSMU Dentistry are you in? |
| 4th year |
| 5th year |
| Bisphosphonates are prescribed (choose one or more answers you think are correct): |
| For patients with osteoporosis |
| For patients with Paget's disease |
| For metastases in bones |
| For gastrointestinal tract metastases |
| Choose the correct answers about bisphosphonates (several correct answers are available): |
| For oral use only |
| For intravenous use only |
| For both oral and intravenous use |
| One of the main properties of bisphosphonates is the activation of bone resorption |
| One of the main properties of bisphosphonates is the inhibition of bone resorption |
| Absorption of oral bisphosphonates is better compared to intravenous bisphosphonates |
| Absorption of intravenous bisphosphonates is better compared to oral bisphosphonates |
| How did you find out about bisphosphonates? |
| From the scientific literature |
| From materials provided by the lecturers |
| From courses |
| I do not think I know enough about bisphosphonates |
| Who do you think can perform tooth extraction for patients taking bisphosphonates? |
| Only a dentist |
| Only a dentist specialist |
| Both |
| Choose the most appropriate term for medication-induced osteonecrosis: |
| Exposed, necrotic bone that does not heal within 4 weeks in patients receiving bisphosphonate therapy, in the absence of radiation therapy and no metastases are diagnosed. |
| Exposed, necrotic bone that does not heal within 8 weeks in patients receiving bisphosphonate therapy, in the absence of radiation therapy and no metastases are diagnosed. |
| Exposed, necrotic bone that does not heal within 4 weeks in patients receiving bisphosphonate therapy and jaw radiation therapy and metastases are diagnosed. |
| Exposed, necrotic bone that does not heal within 8 weeks in patients receiving bisphosphonate therapy and jaw radiation therapy and metastases are diagnosed. |
| Choose one or more correct answers about bisphosphonate-induced osteonecrosis: |
| Bisphosphonate-induced osteonecrosis is more common in the upper jaw |
| Bisphosphonate-induced osteonecrosis is more common in the lower jaw |
| Bisphosphonate-induced osteonecrosis is more dangerous for those who take them orally |
| If a patient who is taking bisphosphonates needs tooth extraction, your strategy is: |
| I would refer the patient to a specialist |
| I would do tooth extraction myself |
| I do not know |
| Are you familiar with the classification of drug-induced osteonecrosis? |
| Yes |
| No |
|
Would you be able to identify the stage of the bisphosphonate-related osteonecrosis of the jaw and assign the required treatment? (If you answered NO to the previous question, skip this question) |
| I have heard about the classification of the disease, but I would not be able to identify the stage of the disease and assign the treatment required. |
| I have heard about the classification of the disease and will be able to identify the stage of the disease and assign the required treatment |
| Is there a need for more university education on bisphosphonates and the osteonecrosis they cause? |
| Education is only required for bisphosphonate-induced osteonecrosis |
| Education is needed on both bisphosphonate-induced osteonecrosis and bisphosphonates |
| No, we get enough information |
| I do not know |